Home spirometry Bluetooth device market seen growing to $2.08 billion by 2030

The home spirometry Bluetooth device market is projected to rise from $1.28 billion in 2025 to $1.42 billion in 2026, then reach $2.08 billion by 2030, according to The Business Research Company. Growth is being driven by rising chronic respiratory disease rates, wider home monitoring adoption and expanding telehealth use.

Why it matters: - Home spirometry Bluetooth devices let patients monitor lung function at home and share respiratory data wirelessly with clinicians. - The market is growing as health systems shift more respiratory care outside hospitals. - The category matters for patients with chronic lung disease who need frequent monitoring and early intervention.

What happened: - The Business Research Company published a 2026 market report on the global home spirometry Bluetooth device market. - The report projects market value will rise from $1.28 billion in 2025 to $1.42 billion in 2026. - The report forecasts the market will reach $2.08 billion by 2030. - The report puts the forecast compound annual growth rate at 10.2% from 2026 to 2030. - The report was released Aug. 11, 2026, from London. - A free sample of the report is available online. - The full market report is also available online.

The details: - Home spirometry Bluetooth devices measure lung function and airflow capacity. - The devices collect respiratory data in real time and transmit it wirelessly to smartphones or tablets. - The wireless workflow supports continuous breathing-pattern monitoring without frequent hospital visits. - The report says the market’s recent growth has been supported by rising chronic respiratory disease rates, rapid adoption of home health monitoring tools, Bluetooth technology improvements, higher patient awareness of self-monitoring and integration with hospital systems. - The report says future growth will be supported by AI-powered respiratory analytics, expansion of telehealth and remote care programs, broader adoption by homecare providers and stronger demand for ongoing pulmonary monitoring. - Chronic respiratory disease prevalence is a major demand driver because these conditions reduce lung function and require ongoing tracking. - The report links higher disease burden to an aging population and greater exposure to environmental pollutants. - In May 2025, the US Centers for Disease Control and Prevention said chronic obstructive pulmonary disease was the fifth leading cause of death in the US in 2023, with 141,733 fatalities. - The CDC also said 3.8% of US adults age 18 and older were diagnosed with COPD that year. - The report says better Bluetooth connectivity is making devices more reliable and easier to use. - The report says integration with hospital information systems helps clinicians access patient data remotely and improves continuity of care.

Between the lines: - The market forecast reflects a broader move toward decentralized care, where patients monitor chronic conditions from home and clinicians intervene earlier when readings change. - North America held the largest market share in 2025, which points to stronger spending and faster adoption of advanced medical devices. - Asia-Pacific is expected to post the fastest growth during the forecast period as healthcare infrastructure expands, respiratory awareness rises and telemedicine programs spread. - The regional coverage also includes South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report’s added tools — including market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics — signal a more data-heavy sales pitch for investors and operators.

What's next: - The market’s next phase likely depends on how quickly AI-enabled analytics and remote care programs move from early adoption to standard practice. - Homecare providers and telehealth platforms may become larger buyers as remote pulmonary monitoring becomes more routine. - Regional growth momentum is likely to stay strongest in Asia-Pacific if infrastructure and telemedicine investment continue.

The bottom line: - Home spirometry Bluetooth devices are moving from niche monitoring tools toward a larger role in chronic respiratory care, with double-digit growth expected through 2030.